Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Work
Year: 2012
Type: article
Source: The Lancet
Institutions University Hospitals of Leicester NHS Trust, Glenfield Hospital, University Medical Center of the Johannes Gutenberg University Mainz, Johannes Gutenberg University Mainz, Southampton General Hospital +9 more
Cites: 28
Cited by: 2,034
Related to: 10
FWCI: 70.78
Citation percentile (by year/subfield): 99.99
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed